News
MuReva Phototherapy presents data from pilot study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation (PBM) Device during the ASTRO 2023 Annual Meeting
MuReva Phototherapy presented data from a pilot prospective study of the company's Intraoral Photobiomodulation (PBM) Device during the the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting held from October 1-4, 2023 in San Diego, California. The company reported results...
MuReva Phototherapy presents data from pilot study of company’s photobiomodulation device during 2023 MASCC Annual Meeting
MuReva Phototherapy presented data from a pilot trial incorporating the us a the company's LED=based intraoral Photobiomodulation (PBM) device for daily use in head and neck cancer patients undergoing radiation therapy during the 2023 Annual Meeting of the Multinational Association Of...
MuReva Phototherapy to present at Five•Ten•Thirty program during San Diego Innovation Day
As a result of being selected as a 2022 "Cool Company" by Connect, a San Diego-based organization that helps promote top technology and life sciences startups for funding, MuReva Phototherapy will be presenting at the Five·Ten·Thirty program which is a part of the 1st Annual Innovation Day...
MuReva Phototherapy Selected as One of Top Emerging Life Sciences Companies in Southern California
MuReva Phototherapy announced today that they have been selected as one of the 2022 "Cool Companies" by Connect, a San Diego-based organization that helps promote top technology and life sciences startups for funding. Cool Companies is an annual Connect program designed to match innovative...
MuReva Phototherapy gains investment from the Angel Physicians Fund and adds Manish Bhandari, MD, E-MBA to Board of Directors
MuReva Phototherapy has announced that the Angel Physicians Fund has made an investment in the company and in conjunction with this investment, Manish Bhandari, MD, E-MBA will join the company's Board of Directors. MuReva plans to utilize this funding to continue the development of the...
MuReva Phototherapy Awarded 1st Place at KJK New Venture Pitch contest during Cleveland Smart Business Dealmakers Conference
MuReva Phototherapy announced that the company won the KJK Venture Pitch competition that was held during the Cleveland Smart Business Dealmakers Conference held on September 2, 2020. The annual Dealmakers Conference connects hundreds of Northeast Ohio business leaders — from middle-market...
MuReva Phototherapy announces initiation of clinical study in patients with head and neck cancer
MuReva Phototherapy has announced that the company has initiated a prospective, multi-center, randomized, double-blind, and placebo controlled pivotal clinical study. This study is designed to evaluate the safety and the efficacy of the MuReva Phototherapy System to reduce the incidence of...
MuReva Phototherapy completes NIH Commercialization Accelerator Program
MuReva Phototherapy has announced that the company has completed the National Institutes of Health (NIH) Commercialization Accelerator Program (CAP) which is only available for Phase II SBIR & STTR Awardees. The NIH CAP is a 9-month program run by the Larta Institute that enables...
MuReva Phototherapy’s CEO included in Crain’s Cleveland Business’ list of “Twenty in their 20s”
Vedang Kothari, President and CEO of MuReva Phototherapy, has been named to Crain's Cleveland Business' 2019 list of "Twenty in their 20s". This list of individuals, which includes active, driven young professionals who will help steer the course of Northeast Ohio into that future, was...
Crain’s Cleveland Business – Lumitex powers up phototherapy startup MuReva
Lumitex spins out a new company, MuReva Phototherapy Inc., based on project initiated by Vedang Kothari, who has been appointed as the new company's President and CEO. The company will focus on the development and commercialization of a technology which uses phototherapy to treat oral...